What is androgenetic alopecia?
At its core is a genetically determined sensitivity of certain hair follicles to dihydrotestosterone (DHT), a derivative of testosterone. The follicles at the forehead, temples and crown are mainly affected, while the fringe at the sides and back of the head is less sensitive. Under the influence of DHT, the sensitive follicles shrink over the years. This process is called miniaturisation. [2] Women can be affected too, but their hair loss follows a different pattern. [1]
The hair does not simply fall out. With each new cycle it grows back slightly shorter, finer and lighter, until strong terminal hairs have turned into barely visible fine vellus hairs. [2] That is why many people first notice not the loss itself but that their hair looks thinner, the scalp shows through or their hairstyle no longer sits the same way. Androgenetic alopecia is not caused by poor hair care, wearing caps or frequent washing. Nor is it a sign of too much testosterone in the blood, because what matters is the sensitivity of the follicles. [2]
Key facts and figures
The figures below come from the reviews and studies listed at the end of this page. They describe population groups and say nothing about any one person.
- More than 50% of men over 50 have some degree of hereditary hair loss. [1]
- A review, based on older surveys, reports that 30 to 50% of men develop androgenetic alopecia by age 50. [2]
- In the United States, an estimated 50 million men and 30 million women are affected. [1]
- The Norwood classification, which physicians use to describe the extent in men, was developed in 1975 from 1,000 adult men. The extent increased into older age. [8]
- Losing 50 to 100 hairs a day is normal. Androgenetic alopecia shows less in this number than in hair that becomes thinner. [7]
- In a pull test at the crown, no more than two hairs came out in 97.2% of cases in a study of 181 participants. [6]
Symptoms and typical patterns
In men, hair loss follows a predictable pattern. Typical signs are a hairline receding at the temples, often forming an M shape, and thinning at the back of the head around the crown. Over time both areas can merge, while the fringe of hair at the sides and back of the head is preserved. This fringe is less sensitive to DHT. [2] Physicians often describe the extent using the Norwood-Hamilton scale, which ranges from a slight change at the hairline to extensive hair loss across the top of the head. [2] [8]
In women, hair loss usually develops differently. Instead of a receding hairline, there is often diffuse thinning around the parting, while the front hairline is preserved. [1] The central parting widens, and complete baldness is rare. Because the pattern is less clear-cut in women and other causes such as iron deficiency, thyroid disorders or hormonal changes play a role more often, a medical assessment is especially important here.
Causes and course
The cause is the interplay of a hereditary predisposition and the effect of DHT on sensitive hair follicles. [2] Androgenetic alopecia starts gradually. First signs can appear as early as the teenage years, and the risk increases with age. [1] In women, hair loss is most likely after menopause. [1] Even the survey on which the Norwood classification is based showed that the extent keeps increasing into older age. [8]
The course is individual and cannot be predicted precisely. In some men it progresses slowly over decades, in others faster in phases. Family history gives clues but no certainty, because many genes are involved and both parents can play a role. [1] Without treatment, androgenetic alopecia generally progresses. Very advanced miniaturisation is hardly reversible with medication, because inactive follicles are harder to reach. The question of timing is therefore less about urgency than about information. If you know your own course, you can decide on an informed basis whether and when an assessment makes sense. Regular photos of your hairline and crown in the same light help you spot changes over months.
How it differs from telogen effluvium
Not all hair loss is hereditary. The most important distinction is telogen effluvium, a temporary, diffuse shedding after a trigger such as an illness with fever, surgery, a nutritional deficiency or major stress. [9]
The two forms differ in several ways. Telogen effluvium usually starts suddenly, around two to three months after the trigger, and affects the whole scalp evenly. [9] Androgenetic alopecia starts gradually, follows a pattern and mainly affects the hairline and crown. In telogen effluvium, more whole hairs fall out, while in androgenetic alopecia the hairs mainly become thinner. And while acute telogen effluvium usually resolves once the trigger is gone, androgenetic alopecia generally progresses without treatment. Both can also occur together. Telogen effluvium can unmask androgenetic alopecia that had gone unnoticed. [9] The guide stress and hair loss explains how stress fits in.
When to see a physician
An assessment makes sense whenever you are unsure what is behind your hair loss or are considering treatment. Prescription ingredients require a medical assessment in any case.
Certain signs are a reason not to wait. These include sudden or very heavy hair loss, round or patchy bald spots, redness, scaling, itching or pain of the scalp, hair loss also affecting the eyebrows, eyelashes or beard, and accompanying symptoms such as fatigue, weight changes or menstrual irregularities. An assessment is also particularly useful for women and for very young people, because other causes are more common there. Such signs can point to a different cause, for example alopecia areata, scalp inflammation, iron deficiency or a thyroid disorder. [2] The guide hair loss causes gives a broader overview of possible reasons.
Diagnosis
The physician usually makes the diagnosis from the conversation and the examination. They ask when the hair loss started, how it is changing, whether relatives are affected and whether there are possible triggers. They then assess the pattern and distribution. A dermatoscope, a magnifier with a light, makes differences in hair thickness and therefore miniaturisation visible. [2]
In the pull test, hair is gently tugged. If clearly more than the usual one or two hairs come out, this points to increased active shedding, which fits telogen effluvium better. [6] With an atypical pattern or accompanying symptoms, blood tests can be useful, for example for iron status or the thyroid. If the pattern is clear, extensive testing is often not needed.
Treatment
Androgenetic alopecia cannot be cured, but it can be treated. The goals of treatment are to slow progression, preserve existing hair and, in some people, improve density. [5] Which option fits depends on the pattern, extent, age, sex, medical history, plans to have children and personal preferences. This is a medical decision, not a general recommendation.
The best-studied medical options are minoxidil, which acts on the hair cycle, and the 5-alpha-reductase inhibitor finasteride, which reduces DHT formation. [3] [4] [5] Topical minoxidil is also available without a prescription, finasteride requires one. Dutasteride, another 5-alpha-reductase inhibitor, is also being studied. In Switzerland, it is only authorised for benign prostate enlargement, so use for hair loss would be off-label, and the randomised trials on it ran for 24 weeks. [11] The ingredient pages describe the evidence, risks and status in Switzerland in detail. Other options include low-level laser therapy, platelet-rich plasma (PRP) and hair transplantation. A systematic review found positive study signals for several non-surgical options but stressed differences in data quality. [5] A transplant moves follicles from the fringe but does not stop the process in the remaining hair.
The guide how to use minoxidil explains how topical minoxidil is applied day to day and what to expect in the first months. The guide finasteride efficacy and studies summarises what the trials on finasteride show. How physician-guided access with a prescription works is described in the guide finasteride prescription in Switzerland, and how physicians weigh benefits and risks in the guide finasteride side effects.
The care pathway in Switzerland
In Switzerland, several routes lead to an assessment. Many insured people have chosen an alternative insurance model, such as a family doctor, HMO or Telmed model. In that case the first point of contact is set, and a referral is usually needed to see a dermatologist. [10] Your family doctor can assess the pattern, order blood tests and refer you if needed. In dermatology, trichoscopy and distinguishing rarer hair disorders come to the fore.
There are also telemedicine services that specialise in hair loss. A physician reviews a questionnaire and photos and decides whether treatment is suitable or whether an in-person examination is needed. Telemedicine does not replace an examination when warning signs are present, but it is well suited to assessing a typical pattern. An assessment by your family doctor or a dermatologist is billed to basic insurance, whereas treating hereditary hair loss itself is generally paid out of pocket. [10] The guide online doctor for hair loss describes how an online medical assessment works.
Treat hair loss online in Switzerland: with orva, you start with a medical questionnaire. Licensed Swiss physicians review your information. If medically appropriate, the physician may issue a prescription.
Ingredients in hair loss
Compare how minoxidil, finasteride and dutasteride work, what the evidence shows and what physicians look for.
Dutasteride
Dutasteride inhibits both main forms of 5-alpha-reductase. Its use for hair loss belongs in physician review.
5-alpha-reductase inhibitorFinasteride
Finasteride is a well-studied DHT inhibitor that may be assessed and prescribed by a physician for androgenetic alopecia.
5-alpha-reductase inhibitorMinoxidil
Minoxidil is a well-studied ingredient in androgenetic alopecia. Topical forms have been used for hair loss treatment for many years.
Vasodilator
FAQs
Can androgenetic alopecia be cured?
A complete cure is not currently possible. Physician-guided treatment can slow, stabilise or improve hair density in some people. The effect usually only lasts as long as treatment continues.
At what age does androgenetic alopecia start?
Androgenetic alopecia can begin as early as the teenage years, and the risk increases with age. By age 50, around 30 to 50% of men are affected. In women, it most often appears after menopause.
Is hair loss inherited from the mother or the father?
Both sides can play a role. Androgenetic alopecia is usually polygenic, meaning it cannot be traced to a single gene or to one side of the family.
Does having less testosterone help?
Not necessarily. What matters is not the testosterone level in the blood but how sensitive your hair follicles are to DHT. Men with hair loss often have normal testosterone levels.
Can stress cause hair loss?
Stress can trigger a different type of hair loss (telogen effluvium), but it's not the main cause of androgenetic alopecia. Whether chronic stress influences the course has not been established.
Why does DHT affect scalp and body hair differently?
This is one of the paradoxes researchers are still working to understand. DHT promotes beard and body hair growth while causing scalp hair loss. The exact mechanisms behind this remain an active area of study.
Who assesses hair loss in Switzerland?
The first point of contact is usually your family doctor, who is fixed in a family doctor, HMO or Telmed model. A referral is then usually needed for dermatology. There are also telemedicine services specialising in hair loss that assess a typical pattern and refer you for an in-person examination if there are warning signs.
References
- [1](2023). Androgenetic alopecia. MedlinePlus Genetics, National Library of Medicine. medlineplus.gov
- [2]Asfour L, Cranwell W, Sinclair R. (2023). Male Androgenetic Alopecia - Endotext. ncbi.nlm.nih.gov
- [3]Kaufman KD, Olsen EA, Whiting D, et al. (1998). Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. doi.org/10.1016/s0190-9622(98)70007-6
- [4]Olsen EA, Dunlap FE, Funicella T, et al. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology. doi.org/10.1067/mjd.2002.124088
- [5]Adil A, Godwin M. (2017). The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. doi.org/10.1016/j.jaad.2017.02.054
- [6]McDonald KA, Shelley AJ, Colantonio S, Beecker J. (2017). Hair pull test: Evidence-based update and revision of guidelines. Journal of the American Academy of Dermatology. doi.org/10.1016/j.jaad.2016.10.002
- [7]Do you have hair loss or hair shedding? American Academy of Dermatology. aad.org (Accessed 13.10.2026)
- [8]Norwood OT. (1975). Male pattern baldness: classification and incidence. Southern Medical Journal. doi.org/10.1097/00007611-197511000-00009
- [9]Hughes EC, Syed HA, Saleh D. (2024). Telogen Effluvium. StatPearls, NCBI Bookshelf. ncbi.nlm.nih.gov
- [10]Swiss Confederation. (2024). Federal Act on Health Insurance (HIA), Art. 25, 32, 41 and 62 (SR 832.10). Fedlex. fedlex.admin.ch
- [11]Gubelin Harcha W, Barboza Martínez J, Tsai TF, et al. (2014). A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology. doi.org/10.1016/j.jaad.2013.10.049
We strive for accurate and current information based on scientific sources. Learn about our standards
Medical Disclaimer. This article is for informational purposes only and does not replace medical advice. Speak with a physician about the risks and benefits of treatment. If hair loss starts suddenly, the scalp is inflamed or painful, or another cause may be involved, you should see a physician for an in-person examination.